In the JQ-1 treatment group, the positive signals of CD40 and CD40L were not only increased but also showed mutual proximity and interactions at many locations inside the tumors (Fig. 4A, lower panel), suggesting that c-Myc inhibition can enhance the CD40-CD40L interaction in the osteosarcoma microenvironment. Here, CD40LG is linked to osteosarcoma.